Physical function and all-cause mortality in patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis

被引:8
|
作者
Yang, Li [1 ]
He, Yanwei [2 ]
Li, Xiaoming [1 ]
机构
[1] Southwest Med Univ, Dept Hematol, Affiliated Hosp, Luzhou 646000, Sichuan, Peoples R China
[2] Southwest Med Univ, Dept Orthoped, Affiliated Hosp, Luzhou 646000, Sichuan, Peoples R China
关键词
Chronic kidney disease; Dialysis; Physical function; Mortality; DWELLING OLDER-PEOPLE; HEMODIALYSIS-PATIENTS; HANDGRIP STRENGTH; BODY-COMPOSITION; NUTRITIONAL PARAMETERS; MUSCLE FUNCTION; RISK-FACTORS; GAIT SPEED; EXERCISE; ASSOCIATION;
D O I
10.1007/s11255-022-03397-w
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose The loss of skeletal muscle mass and muscle strength is common in patients suffering from chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing dialysis. The purpose of this study was to conduct a meta-analysis to explore the relationship between physical functional performance and all-cause mortality in CKD and ESRD patients undergoing dialysis. Methods A systematic literature search was conducted on an electronic database up to January 2022, and all data were analyzed using RevMan5 (version 5.3). Results Totally, 19 studies involving 6908 patients were enrolled for analysis. Patients with poor physical functional performance in the handgrip strength (HGS) (hazard ratio [HR] = 1.99, P < 0.00001), gait speed (HR = 2.45, P = 0.0005), 6 m walk test (HR = 2.94, P < 0.01), and timed up and go test (HR = 1.69, P = 0.02) showed increased risk of all-cause mortality than those with good physical functional performance. In continuous analyses, both per 1 kg increase in HGS (95% CI 0.94-0.98; P < 0.00001; I-2 = 47%) and per 1 SD increase in HGS (HR = 0.47 95% CI 0.35-0.64; P < 0.0001; I-2 = 35%) were significantly associated with lower all-cause mortality. Conclusion The present meta-analysis demonstrated that poor physical function outcomes, including grip strength, gait speed, 6MWT, and TUG test, were significantly associated with high all-cause mortality in patients with CKD and ESRD.
引用
收藏
页码:1219 / 1228
页数:10
相关论文
共 50 条
  • [41] Association of mild chronic obstructive pulmonary disease with all-cause mortality: A systematic review and meta-analysis
    Zou, Weifeng
    Ou, Jie
    Wu, Fan
    Fan, Huanhuan
    Hou, Yuyan
    Li, Haiqing
    Deng, Zhishan
    Liu, Shuling
    Hu, Jinxing
    Ran, Pixin
    PULMONOLOGY, 2025, 31 (01):
  • [42] Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: A meta-analysis and sysematic review
    Sun, Liguang
    Hou, Yue
    Xiao, Qingfei
    Du, Yujun
    SCIENTIFIC REPORTS, 2017, 7
  • [43] Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: A meta-analysis and sysematic review
    Liguang Sun
    Yue Hou
    Qingfei Xiao
    Yujun Du
    Scientific Reports, 7
  • [44] Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis
    Kojima, Gotaro
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (11) : 1989 - 1997
  • [45] End-stage Renal Disease in the Middle East: A Systematic Review and Meta-analysis
    Malekmakan, Leila
    Tadayon, Taraneh
    Roozbeh, Jamshid
    Sayadi, Mehrab
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (04) : 195 - 203
  • [46] Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis
    Gotaro Kojima
    International Urology and Nephrology, 2017, 49 : 1989 - 1997
  • [47] Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients
    Spoto, Belinda
    Mattace-Raso, Francesco
    Sijbrands, Eric
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    D'Arrigo, Graziella
    Tripepi, Giovanni
    Zoccali, Carmine
    Mallamaci, Francesca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 181 - 187
  • [48] Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease
    Anantha-Narayanan, Mahesh
    Sheikh, Azfar Bilal
    Nagpal, Sameer
    Jelani, Qurat-ul-Ain
    Smolderen, Kim G.
    Regan, Christopher
    Ionescu, Costin
    Chaar, Cassius Iyad Ochoa
    Schneider, Marabel
    Llanos-Chea, Fiorella
    Mena-Hurtado, Carlos
    JOURNAL OF VASCULAR SURGERY, 2021, 73 (01) : 331 - +
  • [49] The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: Protocol for a systematic review and meta-analysis
    Ramesh S.
    Mann M.C.
    Holroyd-Leduc J.M.
    Wilton S.B.
    James M.T.
    Seely E.W.
    Ahmed S.B.
    Systematic Reviews, 4 (1)
  • [50] Periostin Predicts All-Cause Mortality in Male but Not Female End-Stage Renal Disease Patients on Hemodialysis
    Li, Xitong
    Liu, Yvonne
    Hocher, Johann-Georg
    Chu, Chang
    Reichetzeder, Christoph
    Kalk, Philipp
    Szakallova, Angelika
    Chen, Xin
    Kraemer, Bernhard K.
    Tepel, Martin
    Hocher, Berthold
    CARDIORENAL MEDICINE, 2024, 14 (01) : 407 - 415